EP Patent

EP1375486A1 — Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity

Assigned to Shionogi and Co Ltd · Expires 2004-01-02 · 22y expired

What this patent protects

A compound of the formula (I): wherein Z 4 , Z 5 and Z 9 each is independently carbon atom or nitrogen atom; Y is hydroxy, mercapto or amino; R A is a group of the formula: (wherein C ring is nitrogen-containing heteroaryl) has an inhibitory activity against integrase.

USPTO Abstract

A compound of the formula (I): wherein Z 4 , Z 5 and Z 9 each is independently carbon atom or nitrogen atom; Y is hydroxy, mercapto or amino; R A is a group of the formula: (wherein C ring is nitrogen-containing heteroaryl) has an inhibitory activity against integrase.

Drugs covered by this patent

Patent Metadata

Patent number
EP1375486A1
Jurisdiction
EP
Classification
—
Expires
2004-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.